Ticker LaunchFiled, not priced · TKVA
Salspera, Inc.
Salspera, Inc. publicly filed a registration statement on Form S-1 on Feb 2, 2026 for a proposed initial public offering on Nasdaq under the ticker TKVA, and has not yet priced. Its latest amendment was filed on Mar 20, 2026. Underwriters named in the filing: Kingswood.
Salspera, Inc. develops a new class of immunotherapeutics for solid tumors, known as live biopharmaceuticals. Its lead program, Saltikva, is an orally administered attenuated Salmonella Typhimurium strain engineered to express anti-tumoral agents within the tumor microenvironment.
- Status
- Filed, not priced
- Ticker
- TKVA
- Exchange
- Nasdaq
- First filed
- Feb 2, 2026
- Latest amendment
- Mar 20, 2026
- Underwriters
- Kingswood
- Sector
- Biotech & pharma
- Country / state
- MA
More on this listing for subscribers
- Amendment history
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Feb 2, 2026
- Latest amendment Mar 20, 2026
- All filings on EDGAR CIK 2084032
Other companies in the IPO pipeline
- Feline Culture Holdings LtdFeb 6, 2026
- Gravity AIFeb 6, 2026
- SYNO Capital Group, Inc.Feb 2, 2026
- V Capital Consulting Group LtdJan 28, 2026
- JOYBYTE HOLDINGS LtdJan 27, 2026
- SWOL Holdings Inc.Jan 27, 2026